SCHEMBL30121044

SCHEMBL30121044

Cc1cc(-c2c(C3=CCOCC3)c[n+]([O-])c3cc(OCc4ccccc4)ccc23)ccc1F

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
MAOB P27338 6/20 0.33
TDP1 Q9NUW8 3/20 0.33
HRH3 Q9Y5N1 2/20 0.33
MAOA P21397 1/20 0.33
CASP3 P42574 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
ALOX5 P09917 1/20 0.33
FFAR1 O14842 3/20 0.32
ACHE P22303 1/20 0.32
PPARD Q03181 1/20 0.32
HPGD P15428 2/20 0.32
PKM P14618 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23887788 1.00 NPC1 (0.34) NPC1RAB9AMEN1KMT2AMAOB
SCHEMBL25192641 0.89 MAOB (0.38) NPC1RAB9AMAOBHRH3MAOA
SCHEMBL23888028 0.83 TLR8 (0.39) NPC1RAB9AMEN1KMT2AMAOB
SCHEMBL25544932 0.83 MAPK14 (0.36)
SCHEMBL25194182 0.80 FFAR1 (0.40) NPC1RAB9AMEN1KMT2AMAOB
SCHEMBL25188580 0.80 MAOB (0.37) NPC1RAB9AMAOBTDP1HRH3
SCHEMBL23887863 0.78 MEN1 (0.38) NPC1RAB9AMEN1KMT2AMAOB
SCHEMBL25188617 0.78 NPC1 (0.39) NPC1RAB9AMEN1KMT2AMAOB
SCHEMBL25196127 0.75 MEN1 (0.37) NPC1RAB9AMEN1KMT2AMAOB
SCHEMBL25544751 0.73 MAPK14 (0.36) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4126819-A1 7- OR 8-HYDROXY-ISOQUINOLINE AND 7- OR 8-HYDROXY-QUINOLINE DERIVATIVES AS ALPHA-1 -ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1 -ANTITRYPSIN DEFICIENCY (AATD) Vertex Pharmaceuticals Incorporated (US) 2023-02-08 EP disclosed
CN-115697969-A 7-or 8-hydroxy-isoquinoline and 7-or 8-hydroxy-quinoline derivatives as alpha-1 antitrypsin modulators for the treatment of alpha-1 antitrypsin deficiency (AATD) 弗特克斯药品有限公司 2023-02-03 CN disclosed